Speaker

Mark Mullikin

Chief Financial Officer, Ensem Therapeutics

Mark Mullikin, Chief Financial Officer at Ensem Therapeutics, spoke at Finance & Accounting for Bioscience (Boston, United States of America, 24–25 Sept 2026) in the session “CFO Panel: Redefining Financial Leadership for Organizational Success”.

Conferences: 1
Keynotes: 0
Upcoming: 0

Past appearances

Finance & Accounting for Bioscience
24–25 Sept 2026Boston, United States of America
- PanelCFO Panel: Redefining Financial Leadership for Organizational SuccessWith Kristen Godsoe, Justin Renz, Kathleen Borthwick, Kory Wentworth

More speakers at Finance & Accounting for Bioscience

Maricel Apuli
Chief Accounting Officer, BridgeBio
Maggie Berkeley
Biopharma Sector Leader and Risk Advisory Principal, RSM US LLP
Juan Betanzo
Vice President, Strategic Finance, EyePoint
Kwame Boateng
Independent
Melissa Bradford-Klug
Chief Financial & Business Officer, NorthSea Therapeutics
Jen Cadigan
Partner & Life Sciences Lead, CrossCountry Consulting

See all 37 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Mark Mullikin, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].